Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

Eur Heart J. 2007 Jan;28(1):88-136. doi: 10.1093/eurheartj/ehl260.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Angioplasty, Balloon, Coronary / methods
  • Arrhythmias, Cardiac / therapy
  • Blood Glucose / metabolism
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / therapy*
  • Death, Sudden, Cardiac / prevention & control
  • Diabetes Mellitus, Type 1 / diagnosis
  • Diabetes Mellitus, Type 1 / therapy*
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / therapy*
  • Diabetic Angiopathies / diagnosis
  • Diabetic Angiopathies / therapy*
  • Disease Progression
  • Exercise Therapy
  • Fibrinolytic Agents / therapeutic use
  • Heart Failure / therapy
  • Homeostasis
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperlipidemias / prevention & control
  • Hypertension / prevention & control
  • Myocardial Revascularization / methods
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Stroke / prevention & control

Substances

  • Blood Glucose
  • Fibrinolytic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors